S30Can irinotecan dose reduction according to ugt1a1 genotype avoid severe toxicities?
Daniel, F., Belluomini, L., Lancia, F., Martella, L., Toma, I., Moretti, A., Bannò, E., Carandina, I., Marzola, M., Fabbri, M., Frassoldati, A.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw345.30
Date:
September, 2016
File:
PDF, 33 KB
english, 2016